LYVE1 and neoplasm: Although immunohistochemistry suggested that more lymphatic endothelial cells (Lyve1+) were present in tumors from PyMTΔsEH mice, no significant differences in CD31+, CD146-, or Ly-6C- cells could be detected in tumor lysates.